Startup profile for Incredible Health: latest funding, latest known valuation, total disclosed funding, investors, status, sources, and why the company is interesting. Part of the Venture Capital Tracker startup directory.
Venture Capital Tracker logo
Venture Capital Tracker

Startup profile · funding coverage

Incredible Health funding, valuation and investors

Permanent healthcare hiring marketplace — matches nurses to health systems with AI screening.

Keep track of Incredible Health

Save this profile to your VCT watchlist for a quick return.

View watchlist

Funding, valuation & investors

Answer-first snapshot

Latest funding

Series B

$80M · 2022

Latest known valuation

$1.65B

Series B · 2022

Total disclosed equity funding

$95M

Excludes debt, grants, acquisitions, secondaries, and IPO proceeds.

Current status

private

series b · San Francisco, California

Investors in latest funding

Lead: Base10 Partners

Other: Andreessen Horowitz

Sources: latest funding Last verified: 2026-07-25

Overview

Incredible Health is a permanent healthcare hiring marketplace that uses AI screening to match nurses with health systems — addressing chronic nursing shortages.

Why Incredible Health is interesting

Highest-valued tech-enabled healthcare talent marketplace at Series B; Base10 Advancement Initiative lead.

Product & use cases

Incredible Health is a permanent healthcare hiring marketplace using AI screening to match nurses with health systems — addressing chronic nursing shortages.

  • Permanent nurse placement at health systems
  • AI-powered candidate screening and matching
  • Reducing time-to-hire for nursing roles

Key facts

  • Series A (2019): $15M led by a16z for nurse hiring marketplace — TechCrunch
  • Series B (2022): $80M led by Base10 at $1.65B unicorn; a16z re-upped — company blog

Funding history (newest first)

Series B

2022 $80M Valuation: $1.65B

Source: https://www.incrediblehealth.com/blog/series-b

Series A

2019 $15M

Source: https://techcrunch.com/2019/08/14/incredible-health-series-a

Investors in our directory

Funds linked from Incredible Health's profile — open a fund page for stage focus and related deal articles.

Andreessen Horowitz Base10 Partners

Competitive landscape

Edge: Highest-valued tech-enabled healthcare talent marketplace at Series B ($1.65B) — permanent hires vs. travel nurse staffing.

Nursing shortages cost health systems billions. Incredible Health targets permanent hires — differentiated from travel nurse staffing boom-and-bust cycles.

  • IntelyCare direct

    Nurse staffing marketplace; Incredible Health focuses on permanent placement.

  • AMN Healthcare incumbent

    Travel nurse staffing giant; different permanent vs. contract model.

  • LinkedIn adjacent

    General hiring; Incredible Health nursing-specific AI matching.

  • Aya Healthcare direct

    Healthcare staffing platform; contract-heavy vs. Incredible permanent hires.

Notable stories

  • Unicorn at $1.65B valuation on $80M Series B led by Base10 (2022).
  • a16z led $15M Series A (2019) for nurse hiring marketplace thesis (TechCrunch).

Industries

Healthtech

FAQs about Incredible Health

Practical answers founders, operators, and investors typically search for.

Permanent healthcare hiring marketplace matching nurses to health systems with AI screening.
a16z (/fund/andreessen-horowitz) led Series A ($15M, 2019). Base10 (/fund/base10-partners) led Series B ($80M, 2022) at $1.65B valuation.
Incredible Health targets permanent hires; travel nurse companies fill temporary contract roles.
Series B — $80M at $1.65B valuation (2022).
Dr. Iman Abuzeid and Rome Portlock co-founded Incredible Health in 2017.
Chronic nursing shortages and slow health system hiring processes create matching friction.
AI matches nurse qualifications and preferences to health system openings — specifics on incrediblehealth.com.
No — remains private.
Website All startups Funding news

By Venture Capital Tracker

Last updated:

Editorial note: AI tools assisted with research, structure, or drafting. Venture Capital Tracker retains human editorial responsibility for factual accuracy, relevance, and source quality before publication.